Oral cisapride for the control of delayed vomiting following high-dose cisplatin
β Scribed by Barbara A. Pizzo; Katherine M. W. Pisters; Vincent A. Miller; Stefan C. Grant; Lorraine Baltzer; Linda Hinckley; Mark G. Kris
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 19 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Metoclopramide was administered by continuous infusion to two groups each of 14 patients on chemotherapy, randomized to receive either doses adjusted to individual pharmacokinetic parameters or doses adjusted as usual to body weight. The mean plasma concentration at the end of the infusion in the ad
## Abstract ## BACKGROUND. The combination of palonosetron and aprepitant is safe and effective in the prevention of chemotherapyβinduced emesis (CIE). The purpose of this pilot study was to ascertain the effectiveness of 1βday versus 3βday aprepitant in the prevention of acute and delayed nausea